Company profile
Beyond Air, Inc.
NASDAQ: XAIR · Healthcare · Medical - Devices
#661 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
42DFH 34DQ 40GM 71SS 44
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ return on equity, operating margin
Methodology →Revenue TTM
$7.7M
Rev growth YoY (TTM)
+107.3%
Net income (FY)
-$33.2M
Employees
54
as of 2026-08-25
Market cap
$3.5M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$7.7M$7.7M2026
Net income-$33.2M-$33.2M2026
Operating income-$29.0M-$29.0M2026
Total assets$35.4M$35.4M2026
Liabilities$29.2M$29.2M2026
Equity$6.1M$6.1M2026
Revenue trend
FY2019 – FY2026 · USD
FY19
FY20
FY21
FY24
FY25
FY26
Revenue by segment
Filed disclosures · FY2026
By product
Business100%
By geography
Not disclosed.
The read
What is Beyond Air, Inc.’s revenue?
Beyond Air, Inc. booked $7.7M in FY2026 revenue, growing 107% year over year — faster than most Healthcare companies we track, at a -433.0% net margin.
Peers · Healthcare
Pulmatrix, Inc.46DCrinetics Pharmaceuticals, Inc.53DBolt Biotherapeutics, Inc.39DAmazonas Florestal, Ltd——COSCIENS Biopharma Inc.43DCompuMed, Inc.69BNeighbors
Nassau →Key facts
CEORobert Goodman
SectorHealthcare
IndustryMedical - Devices
HeadquartersGarden City, NY
ExchangeNASDAQ: XAIR
Employees54
IPO date2018-06-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.